How would you approach adjuvant treatment for locally advanced HR+ HER2+ breast cancer in a patient with on immunosuppression due to kidney transplantation?
Original question: How would you approach adjuvant treatment for locally advanced hormonal positive HER2 positive breast cancer in a patient with kidney transplant on immunosuppression who declined neoadjuvant treatment?